Search

everythinglearnresearchcommunity

for

Search:↓

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

New drugs for heart disease may be developed from molecules secreted by stem cells.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).